Video Latest - ecancer

New optimism for advanced breast cancer patients failing antiestrogens: Opening audience survey

Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy

15 Nov 2016

Biology and function of CDKs

Dr Ghadeer Shubassi - Institute of Molecular Oncology, Milan, Italy

15 Nov 2016

Clinical data on breast cancer trials

Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy

15 Nov 2016

CDK 4/6 inhibitors: Management of side effects

Dr Alison Jones - The LOC, London, UK

15 Nov 2016

History of antiangiogenic drugs in multiple myeloma, starting with thalidomide

Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany

2 Nov 2016

How can we make the best decisions for health whilst considering cost?

Dr Andrea Manca - University of York, York, UK

1 Nov 2016

Coming of age for CDK 4/6 inhibitors: Welcome and interactive session

Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy

26 Oct 2016

What are CDKs?

Dr Ghadeer Shubassi - FIRC Institute of Molecular Oncology (IFOM), Milan, Italy

26 Oct 2016

Biomarkers of sensitivity and resistance

Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

26 Oct 2016

Editor's ESMO 2016 roundup

Prof Gordon McVie - Editor in Chief, ecancer

24 Oct 2016

Abiraterone in patients with recurrent epithelial ovarian cancer

Dr Susanna Banerjee - The Royal Marsden, London, UK

24 Oct 2016

Fatigue in men with castration resistant prostate cancer treated with enzalutamide

Dr Simon Chowdhury - Guy's Hospital, London, UK

21 Oct 2016

Video